Business Description
Bausch Health Companies Inc
NAICS : 325412
SIC : 3741
ISIN : CA0717341071
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | -0.04 | |||||
Debt-to-Equity | -21.91 | |||||
Debt-to-EBITDA | 10.14 | |||||
Interest Coverage | 1.2 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.08 | |||||
Beneish M-Score | -2.57 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.6 | |||||
3-Year EBITDA Growth Rate | -2.6 | |||||
3-Year EPS without NRI Growth Rate | -53.2 | |||||
3-Year FCF Growth Rate | -1.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 3.41 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 86.94 | |||||
9-Day RSI | 78.81 | |||||
14-Day RSI | 73.52 | |||||
6-1 Month Momentum % | 11.54 | |||||
12-1 Month Momentum % | 27.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.3 | |||||
Quick Ratio | 0.94 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 181.96 | |||||
Days Sales Outstanding | 76.56 | |||||
Days Payable | 82.46 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | -10.39 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70.78 | |||||
Operating Margin % | 18.25 | |||||
Net Margin % | -6.82 | |||||
FCF Margin % | 8.67 | |||||
ROA % | -2.27 | |||||
ROIC % | 10.71 | |||||
ROC (Joel Greenblatt) % | 45.44 | |||||
ROCE % | 4.21 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 2.9 | |||||
PS Ratio | 0.44 | |||||
Price-to-Free-Cash-Flow | 5.13 | |||||
Price-to-Operating-Cash-Flow | 3.78 | |||||
EV-to-EBIT | 27.33 | |||||
EV-to-Forward-EBIT | 12.69 | |||||
EV-to-EBITDA | 11.61 | |||||
EV-to-Forward-EBITDA | 6.38 | |||||
EV-to-Revenue | 2.91 | |||||
EV-to-Forward-Revenue | 2.69 | |||||
EV-to-FCF | 33.61 | |||||
Price-to-Projected-FCF | 0.65 | |||||
Price-to-Median-PS-Value | 0.47 | |||||
Earnings Yield (Greenblatt) % | 3.66 | |||||
FCF Yield % | 19.51 | |||||
Forward Rate of Return (Yacktman) % | 27.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bausch Health Companies Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 8,120.979 | ||
EPS (TTM) (€) | -1.515 | ||
Beta | 0.79 | ||
Volatility % | 45.7 | ||
14-Day RSI | 73.52 | ||
14-Day ATR (€) | 0.263725 | ||
20-Day SMA (€) | 8.60165 | ||
12-1 Month Momentum % | 27.73 | ||
52-Week Range (€) | 5.141 - 9.817 | ||
Shares Outstanding (Mil) | 365.41 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bausch Health Companies Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bausch Health Companies Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Bausch Health Companies Inc Frequently Asked Questions
What is Bausch Health Companies Inc(FRA:BVF)'s stock price today?
When is next earnings date of Bausch Health Companies Inc(FRA:BVF)?
Does Bausch Health Companies Inc(FRA:BVF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |